The company expects this R&D process to take about two years, but given that even deep-pocketed Apple has been hacking away at its non-invasive glucose monitoring research for reportedly 12 years now, Quantune’s timeline may be ambitious.

Kischkat and Hahne told TechCrunch that the seed funding will also go towards hiring additional staff. The company was previously awarded €5 million ($5.3 million) in public grants awarded by the European Innovation Council (EIC) and the Investment Bank of Berlin (IBB)